Last reviewed · How we verify
NCT05209685
Blood Flow Restriction on Functional Mobility in Pre-frail Older Adults
NA trial testing Resistance exercise on the lower extremities in Frailty in 54 participants. Completed in 31 December 2022.
31 October 2022
Quick facts
| Lead sponsor | National Cheng Kung University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 54 |
| Start date | 17 August 2020 |
| Primary completion | 31 October 2022 |
| Estimated completion | 31 December 2022 |
| Sites | 1 location across Taiwan |
Drugs / interventions tested
- Resistance exercise on the lower extremities
- Resistance exercise on the lower extremities with blood flow restriction
Conditions studied
- Frailty — all drugs for Frailty →
Sponsor
National Cheng Kung University
Who can join
Adults 65 to 95, any sex, with Frailty. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study investigates the effect of blood flow restriction with resistance exercise on functional mobility in pre-frail older adults. It is hypothesized that receiving resistance exercise with blood flow restriction will exhibit better improvement on functional mobility than only receiving resistance exercise in pre-frail older adults.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05209685
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Frailty
Currently open trials in the same condition.
- NCT07481188 — Frailty and Nottingham Hip Fracture Score for Predicting 90-Day Mortality After Hip Fracture Surgery · recruiting
- NCT07519603 — Frailty in Older Adults With Chronic Obstructive Pulmonary Disease (COPD) and Outcomes of the VIVIFRAIL Program · NA · recruiting
- NCT07144527 — Nicotinamide Mononucleotide Supplementation for Exercise Tolerance Improvement in Healthy Older Adults · NA · recruiting
- NCT07392944 — Multicomponent Exercise Program on Physical Function, Cognition and Falls Risk Among Older Adults Living in Nursing Home · NA · recruiting
- NCT07475767 — Ultrasound Indicators of Nutritional Status and Treatment Outcomes in Surgical Patients in the Intensive Care Unit · recruiting
Other National Cheng Kung University trials
Trials by the same sponsor.
- NCT07288905 — Exploring the Effects of Exercise Combined With BFRT on Healthy and Patients With CKD · NA · recruiting
- NCT07509606 — Acute Effect of Different Frequency of Whole Body Vibration (WBV) on Healthy and Chronic Obstructive Pulmonary Disease ( · NA · recruiting
- NCT06474130 — Assessing Cervical Sensorimotor Control With VR in Chronic Neck Pain · completed
- NCT06756113 — Digital Dyadic Empowerment Program on Lifestyle Modification for Chronic Kidney Disease Management · NA · completed
- NCT06542302 — The Effects of Cervical Sensorimotor Control Challenges on Gait Patterns, Cervical Sensorimotor Control During Dynamic T · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05209685 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by National Cheng Kung University
- Last refreshed: 27 November 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05209685.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing